Breztri Aerosol, Metered
Product Images NDC 0310-6616

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Breztri (NDC 0310-6616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide Chemical Structure (Budesonidechemstructure)

FDA Label Image

Carton (Container)

Carton (Container)
This is a medication packaging with dosing instructions and precautions. It is a combination of three active ingredients, budesonide, glycopyrrolate, and formoterol fumarate, intended for inhalation. The medication is prescribed for the treatment of respiratory conditions. However, the dosing instructions also caution against the use of the inhaler beyond three months of initial use or after the date of pouch opening. The product is distributed by AstraZeneca, with a National Drug Code of 30-481 for restricted use by prescription only.*
FDA Label Image

Figure 1 (Figure1)

FDA Label Image

Formoterol Fumarate Chemical Structure (Formoterolfumaratechemstructure)

FDA Label Image

Glycopyrrolate Chemical Structure (Glycopyrrolatechemstructure)

Glycopyrrolate Chemical Structure (Glycopyrrolatechemstructure)
This is not a complete text and cannot be evaluated.*
FDA Label Image

Figure 1 (cartridge)

Figure 1 (cartridge)
The text describes a figure, which may depict an inhaler, with a side view and a top view. The figure includes a dose indicator with a display window and a pointer, a canister, an actuator, a mouthpiece, and a cap. The text suggests that the inhaler is used for medication administration.*
FDA Label Image

Figure 2a, 2b, 2c (dose indicators)

FDA Label Image

Figure 2d (dose indicator diaplay changes color)

FDA Label Image

Figure 3 (priming your inhaler)

Figure 3 (priming your inhaler)
Not available.*
FDA Label Image

Figure 4 (press down)

FDA Label Image

Figure 5 (release a puff of medicine)

FDA Label Image

Figure 6 (remove the cap)

FDA Label Image

Figure 7 (shake inhaler)

FDA Label Image

Figure 8 (breathe out)

FDA Label Image

Figure 9 (close your lips)

FDA Label Image

Figure 10 (breathe in deeply and slowly)

FDA Label Image

Figure 11 (hold your breath)

FDA Label Image

Figure 12 (breath out gently)

FDA Label Image

Figure 13 (replace the cap)

FDA Label Image

Figure 14 (good and bad air flow)

FDA Label Image

Figure 15 (take canister out)

FDA Label Image

Figure 16 (hold under running warm water)

FDA Label Image

Figure 17 (leave air-dry over night)

FDA Label Image

Figure 18 (when dry gently press canister into actuator)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.